Catalyst
Slingshot members are tracking this event:
Kite Expects Initial Phase 1 ZUMA-4 Data in 2016 Evaluating KTE-C19 in Pediatric Acute Lymphoblastic Leukemia
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| KITE |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 04, 2016
Occurred Source:
http://ir.kitepharma.com/releasedetail.cfm?ReleaseID=1002521
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1, Initial Data Release, Kte-c19, Pediatric Acute Lymphoblastic Leukemia, Zuma-4
